Navigation Links
MCG selected as RNA laboratory for worldwide diabetes study
Date:12/17/2007

The Medical College of Georgia Center for Biotechnology and Genomic Medicine has been selected to isolate RNA and DNA from the blood of thousands of children involved in a worldwide study of the causes of type 1 diabetes.

MCG also is enrolling children in the mammoth study that will eventually follow 8,000 at-risk babies from four states and three countries for 15 years, collecting blood every three months as they go.

The TEDDY The Environmental Determinants of Diabetes in the Young study is keeping tabs on many aspects of the childrens lives from emergency room visits to over-the-counter medicines in an effort to identify environmental triggers for diabetes in children with known high-risk genes.

Once you know the risk factors, you can modulate the risk factors to prevent diabetes, says Dr. Jin-Xiong She, center director and Georgia Research Alliance Eminent Scholar in Genomic Medicine.

Dr. She was among the scientists who conceived the idea of TEDDY and successfully applied for National Institutes of Health funding to pursue it in 2003.

He recently was named principal investigator on the additional five-year, $5 million contract to isolate RNA and DNA from the regularly collected blood.

About 20,000 samples already are awaiting the process. The MCG Center developed a robotic automation that processes 96 samples in about two hours compared to the standard of a few samples in about six hours to handle the huge and growing volume.

Gene expression over time is a new area of research, says Dr. She. The newly established infrastructure enables MCG to isolate nucleic acids for similar large-scale studies.

Isolated nucleic acids will be stored at the National Institute of Diabetes and Digestive and Kidney Diseases Repository. TEDDY scientists will eventually analyze the impact of environmental triggers on the bodys basic building blocks with an eye toward identifying biomarkers that give an early heads up that the body is headed toward diabetes.

These two different types of genetic material contain different information, Dr. She explains. The basic information of DNA does not change. What changes in DNA is how it may or may not allow expression of genes. RNA changes all the time.

Think about when you get the flu and your body starts to increase the number of immune cells to fight it, says Dr. Richard A. McIndoe, associate center director and co-principal investigator. That requires an expansion of your cells, which requires an expansion of proteins, which requires an expansion of RNA. Infection is an environmental trigger. Your RNA changed because you had an infection.

When you are getting diabetes, your RNA expression also changes, says Dr. She. Changes may or may not be permanent, but the goal is to connect the pieces and see which changes amount to type 1 diabetes, he says.

MCGs TEDDY Clinical Center is screening newborns in nine hospitals, including MCG Medical Center, University Hospital, Trinity Hospital of Augusta; Northside, Piedmont and Kennestone Hospitals in Atlanta; and three hospitals in Gainesville, Fla. Additional centers include Barbara Davis Center at the University of Colorado; Pacific Northwest Research Institute in Seattle; the University of Turku in Finland; Lund University in Sweden; and the Diabetes Research Institute in Munich, Germany. The University of South Florida in Tampa serves as the TEDDY data coordinating center and MCGs new contract with the NIDDK for nucleic acid isolation is through that university.

To date, MCGs center has enrolled about 500 children. An additional 800 to 1,000 enrollees in the next two-and-one-half years are planned.


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia  
Source:Eurekalert

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Fry Construction Selected for High-Profile Medical Imaging Project
6. Meth Project Advertisements Selected for National Prevention Campaign
7. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
8. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
9. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
10. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
11. CBaySystems Selected to Receive Deloittes 2007 Maryland Technology Fast 50 Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MCG selected as RNA laboratory for worldwide diabetes study
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton ... staged a mock evacuation of the facility as part of a disaster drill on ... Echo Hose EMS and Shelton City Emergency Manager, as well as the Connecticut ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... ARBOR, Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device ... precise destruction of targeted tissues, announced three leadership team developments today:   ... Stopek, PhD ... ... Veteran medical device executive ...
Breaking Medicine Technology: